Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis

被引：0
|
作者：
Lam, Michael [1 ]
Olivier, Timothee
Haslam, Alyson [3 ]
Tuia, Jordan [3 ]
Prasad, Vinay [2 ,3 ,4 ]
机构：
[1] Univ Calif La Jolla, 9500 Gilman Dr, San Diego, CA 92093 USA
[2] Geneva Univ Hosp, Dept Oncol, 4 Gabrielle Perret Gentil St, CH-1205 Geneva, Switzerland
[3] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
[4] Mission Hall Global Hlth Clin Sci Bldg, Dept Epidemiol & Biostat, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 202卷
关键词：
D O I：
10.1016/j.ejca.2024.114019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cost analysis of robotic versus open hepatectomy: Is the robotic platform more expensive?
    Emanuel Shapera
    Iswanto Sucandy
    Cameron Syblis
    Kaitlyn Crespo
    Thomas Ja’Karri
    Sharona Ross
    Alexander Rosemurgy
    Journal of Robotic Surgery, 2022, 16 : 1409 - 1417
  • [2] Cost analysis of robotic versus open hepatectomy: Is the robotic platform more expensive?
    Shapera, Emanuel
    Sucandy, Iswanto
    Syblis, Cameron
    Crespo, Kaitlyn
    Ja'Karri, Thomas
    Ross, Sharona
    Rosemurgy, Alexander
    JOURNAL OF ROBOTIC SURGERY, 2022, 16 (06) : 1409 - 1417
  • [3] Cost Analysis of Nipple-Sparing Mastectomy: Must New Always Be More Expensive?
    Wexelman, Barbara
    Martinson, Holly
    Tang, Rong
    Hughes, Kevin
    Coopey, Suzanne
    Gadd, Michele
    Specht, Michelle
    Smith, Barbara L.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 123 - 124
  • [4] Dynamic Cost-Benefit Analysis of Drug Substitution Programs
    J. P. Caulkins
    G. Feichtinger
    C. Gavrila
    A. Greiner
    J. L. Haunschmied
    P. M. Kort
    G. Tragler
    Journal of Optimization Theory and Applications, 2006, 128 : 279 - 294
  • [5] Dynamic cost-benefit analysis of drug substitution programs
    Caulkins, J. P.
    Feichtinger, G.
    Gavrila, C.
    Greiner, A.
    Haunschmied, J. L.
    Kort, P. M.
    Tragler, G.
    JOURNAL OF OPTIMIZATION THEORY AND APPLICATIONS, 2006, 128 (02) : 279 - 294
  • [6] Cost Analysis of Robotic vs 'Non-Robotic' Hepatectomy: Is the Robotic Platform More Expensive?
    Sucandy, Iswanto
    Ross, Sharona B.
    Jabbar, Furrukh
    Przetocki, Valerie
    Thomas, Ja'Karri M.
    Rosemurgy, Alexander S., II
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S148 - S148
  • [7] Which Bonds Are More Expensive? The Cost Differentials by Debt Issue Purpose and the Method of Sale: An Empirical Analysis
    Guzman, Tatyana
    Moldogaziev, Temirlan
    PUBLIC BUDGETING AND FINANCE, 2012, 32 (03): : 79 - 101
  • [8] An Analysis of The Cost of New Treatments for Multi-Drug Resistant Tuberculosis
    O'Flaherty, Niamh
    Ottewill, Ciara
    McNally, Emma
    Dolan, Lorraine
    O'Reilly, Aoife
    McLaughlin, Anne-Marie
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S156 - S157
  • [9] Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab
    Yifan Xu
    Joel W. Hay
    Afsaneh Barzi
    Cost Effectiveness and Resource Allocation, 16
  • [10] Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab
    Xu, Yifan
    Hay, Joel W.
    Barzi, Afsaneh
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2018, 16
12345